Page 8 - Read Online

40 Robotic gastrectomy for gastric cancer
Masanori Tokunaga, Masahiro Watanabe, Shizuki Sugita, Akiko Tonouchi, Akio Kaito, Takahiro
Kinoshita
J Cancer Metastasis Treat 2018;4:40 http://dx.doi.org/10.20517/2394-4722.2017.80

41 Extracellular control of chromosomal instability and maintenance of intra-tumoral heterogeneity
Yi-Hong Zhou, Kambiz Afrasiabi, Mark E. Linskey
J Cancer Metastasis Treat 2018;4:41 http://dx.doi.org/10.20517/2394-4722.2018.16

42 Genomic heterogeneity meets cellular energetics: crosstalk between the mitochondria and the cell
cycle
Erica L. Herrera, Seham Z. Azzam, Madison C. Berger, Laura A. Diaz-Martinez
J Cancer Metastasis Treat 2018;4:42 http://dx.doi.org/10.20517/2394-4722.2018.35

43 Centrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor
heterogeneity
Shirley Jusino, Fabiola M. Fernández-Padín, Harold I. Saavedra
J Cancer Metastasis Treat 2018;4:43 http://dx.doi.org/10.20517/2394-4722.2018.24

44 Expression and regulation of aldehyde dehydrogenases in prostate cancer
Ali I. M. Ibrahim, Maria Sadiq, Fiona M. Frame, Norman J. Maitland, Klaus Pors
J Cancer Metastasis Treat 2018;4:1-17 http://dx.doi.org/10.20517/2394-4722.2018.07

45 Introduction of the special issue “How does the prostate cancer microenvironment affect the
metastatic process and/or treatment outcome?”
Jason P. Webber, Klaus Pors
J Cancer Metastasis Treat 2018;4:45 http://dx.doi.org/10.20517/2394-4722.2018.46

46 Increased ARF6 activation correlates with HGF stimulation in non-invasive prostate cancer cells
Claire Morgan, Lucy J. Swithenbank, Helen Whiteland, Shareen H. Doak
J Cancer Metastasis Treat 2018;4:46 http://dx.doi.org/10.20517/2394-4722.2018.19

47 Unmasking tumor heterogeneity and clonal evolution by single-cell analysis
Xiaoshan Shi, Papia Chakraborty, Amitabha Chaudhuri
J Cancer Metastasis Treat 2018;4:47 http://dx.doi.org/10.20517/2394-4722.2018.32

48 Introduction to the special issue on reviews of gastric cancer metastasis and treatment
Masayuki Watanabe
J Cancer Metastasis Treat 2018;4:48 http://dx.doi.org/10.20517/2394-4722.2018.60

49 NSAID celecoxib: a potent mitochondrial pro-oxidant cytotoxic agent sensitizing metastatic
cancers and cancer stem cells to chemotherapy
Stephen John Ralph, Sam Nozuhur, Rafael Moreno-Sánchez, Sara Rodríguez-Enríquez, Rhys Pritchard
J Cancer Metastasis Treat 2018;4:49 http://dx.doi.org/10.20517/2394-4722.2018.42